Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis

Clinical and Experimental Immunology

Volumn 113, Issue 1, 1998, Pages 55-58

  North, R J ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

Anti mycobacterial immunity; Cytokines; Th1 Th2

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CHRONICITY; CONTROLLED STUDY; HELPER CELL; IMMUNOREGULATION; INFECTION RESISTANCE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

ANIMALS; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; LIVER; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; TH1 CELLS; TUBERCULOSIS;

EID: 0031869869     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00636.x     Document Type: Article

References (30)

1. Orme IA, Andersen P, Boom WH. T cell response to Mycobacterium tuberculosis. J Infect Dis 1993; 167:1481-9.
2. Boom WH. The role of T cell subsets in Mycobacterium tuberculosis infection. Infect Agents Dis 1996; 5:73-81.
3. Flynn JL, Goldstein MA, Treibold KJ, Koller B, Bloom BR. Major histocompatibility complex class 1-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1992; 89:12013-7.
4. Leveton C, Barnass S, Champion B, Lucas S, De Sousa B, Nicol M, Banerjee D, Rook G. T-cell-mediated protection of mice against virulent Mycobacterium tuberculosis. Infect Immun 1989; 57:390-5.
5. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russel DG, Orme IM. Disseminated tuberculosis in gamma gene-disrupted mice. J Exp Med 1993; 178:2243-7.
6. Flynn JL, Chan J, Tiebold KJ, Dalton DK, Stewert TA, Bloom BR. An essential role for interferon gamma in resistance in Mycobacterium tuberculosis infection. J Exp Med 1993; 178:2249-54.
7. Mosmann TR, Moore KW. The role of IL-10 in cross regulation of Th1 and Th2 response. Immunol Today 1991; 12:A49-A53.
8. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-46.
9. Abbas AK, Murphy KM, Sher AL. Functional diversity of helper T cells. Nature 1996; 383:787-93.
10. Dipiro JT. Cytokine networks with infection: mycobacterial infection, leishmaniasis, human immunodeficiency virus infection, and sepsis. Pharmacother 1997; 17:205-23.
11. Orme IM, Roberts AD, Griffin JP, Abrams J. Cytokine secretion by CD4 lymphocytes in response to Mycobacterium tuberculosis infection. J Immunol 1995; 151:518-24.
12. Hernandez-Pando R, Orozcoe H, Sampieri A, Pavon L, Velasquillo C, Larriva-Sahd J, Alcocer JM, Madrid MV. Correlation between the kinetics of Th1/Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology 1996; 89:26-33.
13. Huygen K, Abramowicz D, Vanenbussche P et al. Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice. Infect Immun 1992; 60:2880-6.
14. Dlugovtzky D, Torres-Morales A, Rateni L, Farron MA, Largach C, Molteni O, Bottasso O. Circulating profile of Th1/Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement. FEMS Immunobiol Med Microbiol 1997; 18:203-7.
15. Sieling PA, Modlin RL. Cytokine patterns at the site of mycobacterial infection. Immunobiol 1994; 191:378-87.
16. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin-10. J Exp Med 1991; 174:1549-55.
17. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Ann Rev Immunol 1993; 11:165-90.
18. / mice: an overview. J Leukocyte Biol 1997; 61:389-97.
19. Murry PJ, Wang L, Onufryk C, Tepper RI, Young RA. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 1997; 158:315-21.
20. Medina E, North RJ. Evidence inconsistent with a role for the Bcg gene (Nrampl) in resistance of mice to infection with virulent Mycobacterium tuberculosis. J Exp Med 1996; 183:1045-51.
21. Dunn PL, North RJ. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology and cause mortality in mice. Infect Immun 1995; 63:3428-37.
22. Cooper AM, Magram J, Farrante J, Orme IM. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 1997; 186:39-45.
23. Coffman RL, Varkila K, Scott P, Chatelain R. Role of cytokines in the differentiation of T-cell subsets in vivo. Immunol Rev 1991; 123:189-207.
24. Kopf M, Gros GL, Bachman M, Lamers MC, Bluethmann H, Kohler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993; 362:245-8.
25. Takeda K, Kanaka T, Shi W et al. Essential role of Stat6 in IL-4 signaling. Nature 1996; 380:627-30.
26. Hsieh C, Heimberger AB, Gold JS, O'Garra A, Murphy KM. Differential regulation of helper phenotype development by interleukins 4 and 10 in αβ T-cell-receptor transgenic system. Proc Natl Acad Sci USA 1992; 89:6065-9.
27. Wheeler PR, Ratlege C. Metabolism of Mycobacterium tuberculosis. In: Bloom BR, ed. Tuberculosis: pathogenesis, protection and control. Washington DC: ASM Press, 1994:353-85.
28. Dunn PL, North RJ. Persistent infection with virulent but not avirulent Mycobacterium tuberculosis in the lungs of mice causes progressive pathology. Med Microbiol 1996; 45:103-9.
29. Farer LS, Lowell AM, Meador MP. Extrapulmonary tuberculosis in the United States. Am J Epidemiol 1979; 109:205-17.
30. Barns PF, Block AB, Davidson PT, Snider DE. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991; 324:1644-50.